Price Alert

CervoMed Inc. (CRVO)

NASDAQ: CRVO · Real-Time Price · USD

10.17

-0.02 (-0.20%)

At close: Aug 15, 2025, 3:59 PM

10.11

-0.59%

After-hours: Aug 15, 2025, 05:20 PM EDT

-0.20% (1D)

Bid	9.3
Market Cap	94.1M
Revenue (ttm)	7.15M
Net Income (ttm)	-18.67M
EPS (ttm)	-2.63
PE Ratio (ttm)	-3.87
Forward PE	-5.14
Analyst	Strong Buy

Ask	10.33
Volume	118,363
Avg. Volume (20D)	366,753
Open	10.10
Previous Close	10.19
Day's Range	10.07 - 10.34
52-Week Range	1.80 - 20.63
Beta	-0.80

About CRVO

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol CRVO

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRVO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

CervoMed has released their quartely earnings on Aug 8, 2025:

Revenue of $1.76M exceeds estimates by $447.2K, with -46.55% YoY decline.

EPS of -0.7 misses estimates by -0.10, with -159.26% YoY decline.

Next Earnings Release

CervoMed Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

-3.45%

CRVO stock has given up its prior gain. CervoMed s... Unlock content with Pro Subscription

2 weeks ago

-3.45%

CervoMed shares are trading higher after the company announced results from its Phase 2 RewinD-LB trial.

News

2 weeks ago · benzinga.com

CervoMed's Dementia Data Show Slowed Disease Progression

CervoMed Inc. CRVO on Monday shared 32-week data from the Extension phase of its Phase 2b RewinD-LB trial evaluating oral neflamapimod in patients with Dementia with Lewy Bodies (DLB).

2 weeks ago · zacks.com

CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains?

CERVOMED INC (CRVO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down th...